ClinicalTrials.gg
Drug

Berzosertib clinical trials

Also written M6620 and VX-970.

studies test it
22
open now
0
in phase 3
0
first study started
2012

How each study uses berzosertib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Berzosertib
16
2-Pyrazinamine, 3-(3-(4-((Methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-
11
M 6620
11

Development codes

M6620
19
VX-970
13

Studies by the year they started

22 studies that test it; most in 2017 (4)

Studies that test berzosertib, by start year
YearStudies
20121
20151
20162
20174
20182
20194
20203
20214
20221

Who runs them

Industry 5 · Other 17

National Cancer Institute (NCI) (14) · EMD Serono Research & Development Institute, Inc. (3) · M.D. Anderson Cancer Center (1) · Merck KGaA, Darmstadt, Germany (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · University of Oxford (1) · Massachusetts General Hospital (1)

Often tested with

Tested in the same studies.

Carboplatin (2) · Veliparib (1) · Avelumab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test berzosertib.

Studies

Open first, then newest update. How each study uses berzosertib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 22

See all 22 studies that test berzosertib →

Given beside what is tested · 1 — berzosertib is usual care or a partner of the new treatment

Codes

What other systems call berzosertib · ClinicalTrials.gg INT000231

  • MeSH (NLM) C000598331berzosertibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) L423PRV3V3BERZOSERTIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27089129berzosertibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C116355BerzosertibOne source FDA
  • DrugBank DB11794One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.